ESET supports the production of 100,000 diagnostic PCR test kits to detect coronavirus

ESET today announced that the ESET Foundation have joined forces with Slovak researchers to support and finance the development of first 100,000 diagnostic polymerase chain reaction (PCR) test to detect the coronavirus SARS-CoV-2, the cause of COVID-19.

Scientists from the Slovak companies MultiplexDX, Lambda Life and ProScience Tech have joined forces with virologists from the Biomedical Center of the Slovak Academy of Sciences (BMC SAV) to develop a reagent kit according to World Health Organization (WHO) protocols for reliable SARS-CoV-2 detection.

Preliminary results of the new test not only show nominal functionality, but also good sensitivity compared to currently used diagnostics. “This means that our test is reliable and accurate and can help diagnose early stage patients. We can produce key components for 100,000 PCR tests within two weeks,” explained Pavol Čekan, founder of MultiplexDX.

“In the process of validation and subsequent registration of the resulting report, we are cooperating with the non-profit organization CCCT SK. This stage is estimated to take about three weeks,” said Adam Andráško of ProScience Tech.

“Virus detection consists of sample collection, RNA isolation and PCR diagnostics, with our joint efforts focused on the last step,” said Ivan Juráš of Lambda Life.

“I believe that the efforts of our scientists will be crowned with success, and that we will have sufficient PCR tests from our own resources for the task at hand, coronavirus detection. This will not only help Slovakia by providing much-needed testing, but will also create a reserve in case there is a shortage of tests globally,” noted Robert Mistrík from the permanent crisis staff.

The ESET Foundation supported the development of the test and provided funding for the first 100,000 units from its fund to support the effective diagnosis and prevention of COVID-19. These tests will be offered as a gift to Slovak state institutions.

“When creating the fund, it was important for us to ensure effective mass-scale diagnostics, which can only be achieved through scientific cooperation. Such a critical situation reveals the importance of supporting science in Slovakia, which the ESET Foundation has been dedicated to for a long time,” said Richard Marko, CEO of ESET.